Error: Could not add to watchlist. X

Synta Pharmaceuticals Corp

+ Watchlist
SNTA:US
NASDAQ GM
2.22
USD
0.04
1.83%
As of 20:10:00 ET on 06/02/2015.
Open
2.21
Day Range
2.14 - 2.25
Volume
1,170,854
Previous Close
2.18
52Wk Range
1.85 - 4.97
1 Yr Return
-44.71%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.81
Market Cap (m USD)
298.414
Shares Outstanding (m)
134.421
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
ADDRESS
45 Hartwell Avenue
Lexington, MA 02421
United States
PHONE
1-781-274-8200
  • Chen Schor
    President/CEO
  • Marc R Schneebaum
    Senior VP/CFO/Treasurer
  • Vojo Vukovic
    Senior VP/Chief Medical Ofcr
  • Wendy E Rieder
    Senior VP/Secy/General Counsel
  • Arthur McMahon "Art"
    Senior VP:Human Resources
Show More